This will eventually have an effect on American casino companies that have made more money from Macau than from Las Vegas the past few years.
Companies such as Wynn, Las Vegas Sands, and MGM Grand have created separate subsidiaries for their Macau businesses, but they're still subject to US laws, like the Foreign Corrupt Practices Act.
Regulators are investigating Sands over allegations of bribery in Macau, and Wynn has disclosed that it is being investigated for alleged violations of the FCPA. If found guilty, the Nevada Gaming Control Board could revoke their licenses.
All these companies have ties to the junkets, of course. Some junkets have even brought revenue to Las Vegas.
Cheung's Neptune is one of three Macau junkets that have been allowed to bring high rollers to Las Vegas, something Nevada regulators have been watching with mounting concern.
Wynn and MGM both used Neptune chairman, Lin Cheuk Fung, as an agent from 2005 to 2009. That means Lin arranged for wealthy gamblers to head to MGM and Wynn casinos to play. The problem is that it's not a very transparent process, and regulators don't have a full handle on who those gamblers are.
"We're getting to understand the junkets and how the VIP rooms operate," Nevada Gaming Control Board member A.G. Burnett told Reuters in October. "We haven't decided whether that's offensive to the way we operate."
In Cheung's case, Nevada may be much closer to coming to a decision. One of his companies has been connected to an illegal World Cup gambling ring that was busted in Las Vegas this summer. Eight people were arrested in the sting, and based on computers and cellphones that federal agents collected from the Caesars Palace villas where they stayed, Cheung's companies were helping the alleged ring settle up with gamblers.
What all this means is that once-thought-untouchable junket operators need to be on their guard from now on, and Macau's VIP rooms will suffer for that.
Reuters It's now undeniable that Chinese President Xi Jinping's corruption crackdown will change Macau's casino business forever.
Cheung Chi Tai, a powerful junket operator, is being investigated for money laundering. The FBI had been monitoring him as an alleged member of the Triad, China's fearsome mafia, since 1992.
He was once the largest shareholder of one of Macau's biggest junkets, Neptune Guangdong Group, and continues to have ties to the company.
As the investigation proceeds, Cheung's assets have been frozen, according to The Wall Street Journal. In other words, Hong Kong regulators are very serious this time, and if someone as powerful as Cheung can go down in flames, no one in Macau's junket world is immune.
Junkets made $30 billion for Macau last year by providing financing for casino high rollers — mostly from mainland China. That's about 70% of Macau's casino revenue, according to Reuters.
Investors give junket operators money in exchange for guaranteed returns of about 1% to 2%. However, since this spring, when one junket operator stole $1 billion in cash from the pool, investors have wanted higher returns for perceived additional risk.
This has already started breaking down the island's casino industry. At first, analysts were hopeful, believing that a free fall in casino revenue that started this summer would somehow find a stopping point, or that a higher volume of retail gamblers would make up for lost high rollers. But none of that has happened.
From the Wall Street Journal - Japan
8:39 pm JST
Apr 28, 2014
Japanese Nobel Winner Latest to Apologize Over Stem-Cell Research
A scandal involving Japanese stem-cell research took a surprising turn Monday when the nation’s most revered researcher in the field, Nobel Prize laureate Shinya Yamanaka, apologized for what he described as poor record-keeping.
The apology came after months of soul-searching in Japan over research ethics. A researcher at the prestigious Riken institute, Haruko Obokata, apologized earlier this month after admitting errors in a paper in the journal Nature that described a possible new method of creating stem cells.
Last week, the head of the Riken panel investigating Dr. Obokata had to resign from the panel after admitting that a paper he co-authored used some of the same improper methods of cutting and pasting images that he had criticized in Dr. Obokata’s work.
On Monday evening, Dr. Yamanaka, a professor at Kyoto University, spoke at a news conference after questions arose about an image in a 2000 paper on which he was the lead author. In the paper, Dr. Yamanaka, then at Nara University, described a protein that played a role in turning embryo cells into cells specific to a part of the body.
The university said it conducted an investigation after Dr. Yamanaka informed administrators about allegations he discovered online that an image in the paper was doctored. It didn’t identify the party raising the allegations.
Kyoto University said it found no problem with the paper’s conclusions, but Dr. Yamanaka acknowledged that he no longer had the lab records that would support the validity of the images.
“I would like to express remorse from my heart and apologize,” he said.
jnichols_9627111 "Wow 6 posts since 2011... I hear you....and thanks for the wisdom...Thump up...."
I used to post periodically on Yahoo until the format change.
You can go to stocktwits under nameofthegame7. Archive my posts.
I don't post they any more, I was just trying to help a few investors
try and make back some of the money they previously lost. Nothing to prove here.
I will not be responding to anymore of your posts. Have a nice evening
I don't post much. I have personally been involved in many a turn around plays of public stocks at the absolute bottom in price. ACTC is beginning to act like all great turn around stories do. They have a corporate road map, and now they have a highly regarded CEO. If as an investor you have been successful in buying turn story stocks at the bottom you should be happy if you bought Advanced Cell Tech between .06 - .07 recently. Clear headed thinking by management to do what needed to be done before not after the highly anticipated peer review report is released as the company has increased the ability of biotech funds and funds in general by several 100s of percent that will be able to buy ACTC stock and most importantly the stock is now margin-able.
What are you talking about. IF the stock falls down to the .06 level I would be willing to buy some more shares. I already have a full position, so if it did drop to .06 it would be willing to buy a 4th wave. Don't try and imply what my motives are other than what I've stated, period
A final point, I have accumulated a very nice position between .06 - .062 If the market is willing to sell me more shares at that .06 buy point again, I will be there to complete my 4th and final wave, call it a bonus wave of buying. I do this professionally for a living and I'M VERY GOOD AT WHAT I DO.
The conference call is a chance for the new CEO to position the company going forward, with any new leadership comes the mission statement moving forward. In order for shareholders of any publicly traded company to benefit long term from positive developments at a company you have to believe in the management team. If you asking why...it's all about the cost of financing dollars. The more confidence the higher the stock price the less dilution which doesn't negatively effect the cap base This is CEO Dr. Wotton public address to current and the very real potential of large shareholders going forward. Do I expect Dr. Wotton to leave investors with upbeat message, of course, why else did he come hear AT THS TME, surely not for the salary, that hardly jet sets you and the family to the Hampton's for more than a weekend or so. As we all know its stock and warrants he's received at very attractive prices, especially, when one considers the time consuming issues of previous managements indiscretions have been resolved
The term Death Spiral funding is a term used to describe a convertible security that converts at a discount to the market price at the time of conversion, but HAS NO FLOOR PRICE PROTECTION.
This type of funding is also referred to as a toxic convertible or floorless convertible since the investor can keep converting below the market which in many instances can greatly dilute the companies shareholders and continually drive the price of the shares down.
The lack of a floor price on a convertible security is a very risky way for a company to raise capital. Small companies that cannot otherwise raise capital sometimes have no funding options available to them and there only option, as a last resort, is to accept a death spiral convertible funding structure.
There are exceptions or a few scenarios to why a company would do toxic convertible funding.
Do your own due diligence reviewing all SEC filings, don't relieve on the company press releases or place much value in services that are being paid to promote a company's story
Just another classic example of what toxic money can do to public shareholders equity investment -
The average shareholder, who is typically not involved in the day-to-day operations of the company, relies on several parties to protect / further his / her interests. These parties include the employees, its executives and its board of directors. However, each one of these parties has its own interests, which may conflict with those of the shareholder.
The board of directors is elected by the shareholders of a corporation to oversee and govern management and to make corporate decisions on their behalf. As a result, the board is directly responsible for protecting and managing shareholders' interests in the company. If that was the case toxic financing would not be tolerated by the members of the board.
For a board of directors to be truly effective, it needs to be objective and proactive in its policies and dealings with management. This helps to ensure that management is generating shareholder value. A more objective board of directors, or one that is separate from a company's management, is more likely to promote or protect the interests of the company's shareholders. For example, a board of directors made up entirely or primarily of management would clearly be hampered by conflicts of interest, and the preservation of shareholder value might not be a priority.
Although the average shareholder does not have control over the board of directors or the day-to-day operations of the company, the ultimate responsibility for the protection of shareholder value lies with each individual investor. The investor is ultimately responsible for reviewing corporate policy and governance as well as for the compensation of managers.
Final point, its still possible to regain investors confidence, but again that takes a degree skill in managing a turn around
I don't own any shares but was asked to look into the stock for someone else when the stock was trading in the high .85 range. Please do yourself a favor and look up all the stocks connected to Asher funding dollars. Keep an eye on the stock price at the time of Asher funds and the stock price over the next 6-10 months. You will not be able to find that I'm aware, 1 stock who's stock price appreciated 1%. from the time they excepted the toxic funds. Most of the time the stocks fell between 60 - 85% or more. Sever dilution is what I'm talking abou. tAsher is very well know in the penny stock area and shouldn't be hard to research. Keep in mind this point: A company does NOT turn to Asher unless they have no other choice. I could get into great detail about toxic nature of the funds but I'm sure you can all figure it out. Take care all the very best
ITEN managements willingness to take dollars from Asher should have put the brakes on any additional share purchases by the student body. For all willing to do a little due-diligence go back and follow any and all stocks that take dollars from Asher, especially with NO FLOOR on the stock when the note is converted into shares. The sad thing its almost impossible that current management wasn't aware of the consequences. Still lower to go with ups and downs alone the way, ultimately stock should bottom somewhere below .20
(This may have already been posted)
NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
I/P ENGINE, INC.,
Plaintiff - Appellee
AOL INC., GOOGLE INC., IAC SEARCH &
MEDIA, INC., GANNETT COMPANY, INC.,
Defendants - Appellants
Appeal from the United States District Court for the
Eastern District of Virginia in case no. 2:11-cv-00512-
RAJ-TEM United States District
Judge Raymond Alvin Jackson
O R D E R
I/P ENGINE, INC. V. AOL INC.
Upon consideration of the Appellants, Target
Corporation, et al. unopposed motion to extend time to file
appellant principal brief until April 07, 2014,
IT IS ORDERED THAT:
The motion is granted.
FOR THE COURT
March 10, 2014 /s/ Daniel E. O'Toole
Daniel E. O'Toole
Clerk of Court
Please excuse me, no one asking for any board member or any part of management to go out on the line and if you don't think this question is asked off record then your just being silly! I am a nice long term holder buying in at the low three's. Investors have every reason to ask what management intends to do with the funds if the case is settled in there favor, since the analyst community is going to need a reason outside of the present business models rate of returns to give a damn. Management can refuse to answer or not........Since I do this very successfully, it is not uncommon for shareholders to look for some clarity once the case has been settled what management intentions are. This would not be the first time nor the last time management gave a roadmap for the use of the dollars. If the co wants big investors they need to have the ability to hedge a position as it relates to probable outcomes and use of the dollars
This is a very simple strategy that has been used by many of the biggest company's. Let the
shareholders know in advance how the money is going to be spent......
Personally, I believe this is a meaningless investor conference call, unless you are willing to
inform current shareholders and others who might be evaluating an investment in VRNG
shares on what the proceeds from the GOOG patent award will be used for(were not talking
about when, just the certainty that management will use the process to buy back shares)if
not investors might conclude its dead money for now. Even if you get a quick settlement
unless management is going to be YHOO shareholder friendly, this is a waste of time.
Other than trying in the conf call to publicly show clearly that Google's management are a
bunch of snakes, but who doesn't already know that to be true.
What share holders need is more than just clarity, they want to know more and what better way
to get the analyst community on your side but to do what Yahoo's CEO Meyers did, she
preannounced what the proceeds YHOO was to be receiving from selling part of their
Alibaba stake were to be used for a buying back of $2Bil of Yahoo's outstanding shares, a lot
of shares.... the ride-up started way before the Alibaba asset sale happened, and keep going
from $13 way past $30....touching $40 a share. That share price appreciation as we know,
wasn't because Yahoo's earnings were showing much of an uptick.
If your going to play a public game of chess you might as will try and win.
All the best, Daniel